🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the makers of Tylenol, claiming the corporations withheld safety concerns that the drug presented to pediatric neurological development.

The lawsuit follows a month after Donald Trump advocated an unproven link between using acetaminophen - referred to as paracetamol - during pregnancy and autism in offspring.

Paxton is taking legal action against J&J, which formerly manufactured the medication, the exclusive pain medication suggested for women during pregnancy, and Kenvue, which presently makes it.

In a declaration, he said they "betrayed America by profiting off of suffering and pushing pills without regard for the dangers."

Kenvue states there is insufficient reliable data linking acetaminophen to autism spectrum disorder.

"These companies misled for generations, deliberately risking countless individuals to line their pockets," Paxton, from the Republican party, declared.

Kenvue commented that it was "seriously troubled by the perpetuation of misinformation on the reliability of acetaminophen and the potential impact that could have on the welfare of American women and children."

On its website, Kenvue also said it had "continuously evaluated the relevant science and there is lacking reliable evidence that shows a verified association between consuming paracetamol and autism spectrum disorder."

Organizations speaking for doctors and medical practitioners agree.

The American College of Obstetricians and Gynecologists has stated acetaminophen - the key substance in acetaminophen - is a restricted selection for women during pregnancy to address discomfort and elevated temperature, which can present major wellness concerns if ignored.

"In more than two decades of research on the use of paracetamol in gestation, zero credible investigations has definitively established that the use of paracetamol in any period of pregnancy results in neurodevelopmental disorders in young ones," the association said.

This legal action references current declarations from the Trump administration in claiming the drug is reportedly hazardous.

Last month, the former president raised alarms from health experts when he instructed women during pregnancy to "struggle intensely" not to consume acetaminophen when sick.

The FDA then issued a notice that physicians should contemplate reducing the use of Tylenol, while also declaring that "a causal relationship" between the medication and autism spectrum disorder in children has not been established.

Health Secretary Kennedy, who manages the FDA, had pledged in spring to conduct "a massive testing and research effort" that would establish the origin of autism in a limited time.

But authorities cautioned that finding a sole reason of autism spectrum disorder - considered by experts to be the result of a complex mix of genetic and external influences - would prove challenging.

Autism spectrum disorder is a category of lifelong neurodivergence and condition that impacts how individuals perceive and engage with the environment, and is identified using medical professional evaluations.

In his court filing, the attorney general - who supports Trump who is running for US Senate - alleges Kenvue and Johnson & Johnson "intentionally overlooked and tried to quiet the science" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the firms "remove any marketing or advertising" that states Tylenol is safe for pregnant women.

The court case parallels the grievances of a group of parents of minors with autism spectrum disorder and ADHD who filed suit against the manufacturers of Tylenol in recently.

Judicial authorities rejected the lawsuit, declaring investigations from the plaintiffs' authorities was lacking definitive proof.